Program
Committee Report
The
Fifteenth Annual Meeting in Kissimmee (Orlando), Florida will be from
November 19-22, 2009 at the Gaylord Palms Resort &
Convention Center with a spectacular program.
There
will be Concurrent Workshops featuring
• Platform
Presentations of Selected Abstracts in Genetics,
Hematopathology, Infectious Diseases and Solid Tumors
• Molecular
Diagnostics and Targeted Therapies of Colon Cancer
• Acquired
Mutations in Myeloproliferative Diseases
• Analysis
of Complex Genetic Disorders
• Technical
Troubles: What Would You Do?
• Breaking
Topics
• New
Strategies for Diagnosis and Prevention of Clostridium
difficile infections
• Puzzlers
by Prior
• Clinical
Utility of Microarrays
• Gene
Patents: The Current Environment
• Molecular
Pathology Using Paraffin-Embedded Tissue
• Career
Development Workshop: A look Inside the Options
Those
who wish to attend Early Bird Sessions, beginning at 7:00AM
will hear about:
• Cystic
Fibrosis Newborn Screening
• Detection
of Mutations with Prognostic Implications in AML
• Coding
Conundrums
• New CDC
Guideline for Molecular Genetic Testing for Heritable
Diseases:
• What
Laboratories Should Know and Why?
• Web-Based
Tools and
• QA/QC
for MicroArrays
• Getting
Funded - A Workshop for Researchers
• Molecular
Genetic Testing for Heritable Diseases
• MicroArrays
for Mitochondrial Diseases
• Response
of Molecular Diagnostic laboratories to H1N1.
This
meeting will also feature Early Bird Small Group Workshops
open to up to 30 people
devoted to Alternative Performance
Assessment Strategies; Biostatistics, Epidemiology, and
Molecular Diagnostics; CYP450 Testing: A Forum to Share
Experiences of Using the Roche Amplichip; Solid Tumors:
Challenging Cases and Diagnostic Dilemmas; or participate in
the formation of an Informatics Interest Group,
International Chapter, or Rocky Mountain States Regional
Interest Group.
The
four Plenary Sessions (Genetics, Solid Tumors, Hematopathology and Infectious Diseases) will feature talks
on Complex diseases of Childhood, The Cancer Genome Atlas, NFKB Activation in Non-Hodgkin Lymphoma and
Mass Spectrometry for Infectious
Diseases Applications rounding out a scientific program
highlighted by The AMP Award for Excellence in
Molecular Diagnostics lecture by Kay Davies of Oxford
University.
Details of all the scientific sessions can be obtained by
accessing the AMP Web Site at
www.amp.org/2009/program.htm.
and Subdivision Reports in this Newsletter.
The
AMP Business Meeting on Saturday, November 22 is guaranteed
to generate both light and warmth, as time will be available
to discuss AMP participation in the ACLU litigation seeking
to end “gene patents.” While AMP is mostly about science,
the “Social Event” will make an encore performance for the
second year, providing an opportunity to celebrate
AMP's 15th Anniversary and to have fun with friends that
one may see only once a year.
The
Meeting Program is the result of hard and effective efforts
by both AMP members who have suggested Plenary topics,
Workshops and Early Bird Sessions and Program Committee
members who have forged these suggestions into a coherent
and comprehensive scientific program. I thank Program
Chair-Elect Barbara Zehnbauer, and Committee members
Hanna Rennert, Arlene Buller, Kojo
Elenitoba-Johnson, Tim Greiner, Rick Nolte,
David Persing, Antonia Sepulveda, Loren
Joseph, Joan Gordon and Steven Cook.
Thanks also to our Social Event Chair Roberta Wisotzkey,
together with Mary Williams and Maricel
Herrera from the AMP Office for their gift of time and
energy. We all thank the AMP membership for giving us all
the opportunity to develop this program.
A
final note: The Pre-registration deadline is October 14.
After this date, only onsite registrations is available, at
an increased rate.
|
